IGFBP2 and colorectal carcinoma: Deciphering the molecular mechanisms of IGFBP2 in CRC, its transcriptional activation via NF-κB leads to an upregulation of the Wnt/β-catenin signaling pathway [31], a common feature shared with MACC1 activity.